⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for refractory childhood hodgkin lymphoma

Every month we try and update this database with for refractory childhood hodgkin lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerNCT00027820
Adult Acute Mye...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
Childhood Renal...
Chronic Myelomo...
Clear Cell Rena...
de Novo Myelody...
Metastatic Rena...
Previously Trea...
Progression of ...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Anem...
Refractory Anem...
Refractory Chil...
Refractory Chro...
Renal Medullary...
Type 1 Papillar...
Type 2 Papillar...
Untreated Adult...
Untreated Adult...
Untreated Child...
Fludarabine Pho...
Total-Body Irra...
Peripheral Bloo...
Nonmyeloablativ...
Cyclosporine
Mycophenolate M...
- Fred Hutchinson Cancer Center
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s LymphomaNCT00900250
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Ann Arbor Stage...
Refractory Chil...
Cytology Specim...
- Children's Oncology Group
Ex Vivo Drug Sensitivity Testing and Mutation ProfilingNCT03860376
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Chil...
Refractory Chil...
Refractory Chil...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Chro...
1 Day - 21 YearsFlorida International University
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaNCT01008462
B-Cell Prolymph...
Hypodiploidy
Loss of Chromos...
Plasma Cell Leu...
Progression of ...
Recurrent Adult...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Chron...
Recurrent Plasm...
Recurrent Small...
Refractory Chil...
Refractory Chro...
Refractory Non-...
Refractory Plas...
Refractory Smal...
t(14;16)
t(4;14)
T-Cell Prolymph...
Waldenstrom Mac...
Allogeneic Bone...
Allogeneic Hema...
Autologous Hema...
Autologous-Allo...
Carmustine
Cyclophosphamid...
Cytarabine
Etoposide
Fludarabine Pho...
Laboratory Biom...
Melphalan
Mycophenolate M...
Peripheral Bloo...
Tacrolimus
Total-Body Irra...
- 75 YearsFred Hutchinson Cancer Center
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin LymphomaNCT01780662
Recurrent Adult...
Recurrent Child...
Refractory Chil...
Brentuximab Ved...
Gemcitabine Hyd...
13 Months - 30 YearsNational Cancer Institute (NCI)
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory LymphomaNCT00005803
Prolymphocytic ...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Chron...
Recurrent Non-H...
Recurrent Small...
Refractory Chil...
Refractory Chro...
Refractory Hodg...
Refractory Non-...
Refractory Smal...
T-Cell Chronic ...
T-Cell Prolymph...
Autologous Hema...
Autologous-Allo...
Carmustine
Cyclophosphamid...
Cyclosporine
Cytarabine
Etoposide
Fludarabine Pho...
Laboratory Biom...
Melphalan
Mycophenolate M...
Nonmyeloablativ...
Peripheral Bloo...
Therapeutic Aut...
Total-Body Irra...
- 75 YearsFred Hutchinson Cancer Center
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory LymphomaNCT00005803
Prolymphocytic ...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Chron...
Recurrent Non-H...
Recurrent Small...
Refractory Chil...
Refractory Chro...
Refractory Hodg...
Refractory Non-...
Refractory Smal...
T-Cell Chronic ...
T-Cell Prolymph...
Autologous Hema...
Autologous-Allo...
Carmustine
Cyclophosphamid...
Cyclosporine
Cytarabine
Etoposide
Fludarabine Pho...
Laboratory Biom...
Melphalan
Mycophenolate M...
Nonmyeloablativ...
Peripheral Bloo...
Therapeutic Aut...
Total-Body Irra...
- 75 YearsFred Hutchinson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: